Posted by Michael Wonder on 20 Nov 2022
PHARMAC welcomes Myeloma NZ as first patient advocacy group to present to PTAC
21 November 2022 - Myeloma New Zealand presented directly to PHARMAC’s Pharmacology and Therapeutics Advisory Committee (PTAC) on Thursday, making them the first patient advocacy group to do so.
As PHARMAC continues to work to improve its processes around consumer involvement, PTAC and PHARMAC welcomed Myeloma NZ to present on the lived experiences of those with multiple myeloma in New Zealand.
